Genistein stimulates duodenal HCO3− secretion through PI3K pathway in mice

Biguang Tuo(Zunyi Medical University), Hui Dong(Second Military Medical University), Xuemei Liu(Zunyi Medical University), Ursula Seidler(Medizinische Hochschule Hannover), Jingyu Xu(Nanjing Drum Tower Hospital), Penghong Song(First Affiliated Hospital Zhejiang University), Guorong Wen(Zunyi Medical University)
European Journal of Pharmacology
November 20, 2010
10.1016/j.ejphar.2010.10.070
Cited by 23

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409